[go: up one dir, main page]

GB201709818D0 - Antibodies - Google Patents

Antibodies

Info

Publication number
GB201709818D0
GB201709818D0 GBGB1709818.7A GB201709818A GB201709818D0 GB 201709818 D0 GB201709818 D0 GB 201709818D0 GB 201709818 A GB201709818 A GB 201709818A GB 201709818 D0 GB201709818 D0 GB 201709818D0
Authority
GB
United Kingdom
Prior art keywords
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1709818.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kymab Ltd
Original Assignee
Kymab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kymab Ltd filed Critical Kymab Ltd
Priority to GBGB1709818.7A priority Critical patent/GB201709818D0/en
Publication of GB201709818D0 publication Critical patent/GB201709818D0/en
Priority to RU2019104980A priority patent/RU2764548C2/en
Priority to CN201780045638.9A priority patent/CN109689688B/en
Priority to CN202310636091.7A priority patent/CN116640214A/en
Priority to CA3032897A priority patent/CA3032897A1/en
Priority to KR1020237009918A priority patent/KR20230044038A/en
Priority to JP2019529699A priority patent/JP7198752B2/en
Priority to TW106126908A priority patent/TWI760352B/en
Priority to PCT/GB2017/052352 priority patent/WO2018029474A2/en
Priority to KR1020197006706A priority patent/KR102604433B1/en
Priority to BR112019002529-4A priority patent/BR112019002529A2/en
Priority to CN202310348318.8A priority patent/CN117736325A/en
Priority to EP17752162.2A priority patent/EP3497128A2/en
Priority to US16/323,980 priority patent/US11858996B2/en
Priority to US15/698,600 priority patent/US9957323B2/en
Priority to EP17840565.0A priority patent/EP3559041A1/en
Priority to US16/471,161 priority patent/US20200190191A1/en
Priority to PCT/GB2017/053826 priority patent/WO2018115859A1/en
Priority to JP2019533195A priority patent/JP7290568B2/en
Priority to US17/727,309 priority patent/US20220403029A1/en
Priority to US17/727,288 priority patent/US20220380467A1/en
Priority to JP2022089801A priority patent/JP7448586B2/en
Priority to JP2023016174A priority patent/JP7750887B2/en
Priority to US18/499,431 priority patent/US20240158502A1/en
Priority to JP2023205810A priority patent/JP7781129B2/en
Ceased legal-status Critical Current

Links

GBGB1709818.7A 2016-06-20 2017-06-20 Antibodies Ceased GB201709818D0 (en)

Priority Applications (25)

Application Number Priority Date Filing Date Title
GBGB1709818.7A GB201709818D0 (en) 2017-06-20 2017-06-20 Antibodies
PCT/GB2017/052352 WO2018029474A2 (en) 2016-08-09 2017-08-09 Anti-icos antibodies
EP17752162.2A EP3497128A2 (en) 2016-08-09 2017-08-09 Anti-icos antibodies
US16/323,980 US11858996B2 (en) 2016-08-09 2017-08-09 Anti-ICOS antibodies
CN202310636091.7A CN116640214A (en) 2016-08-09 2017-08-09 Isolating Antibodies and Their Applications
CA3032897A CA3032897A1 (en) 2016-08-09 2017-08-09 Anti-icos antibodies
KR1020237009918A KR20230044038A (en) 2016-08-09 2017-08-09 Anti-icos antibodies
JP2019529699A JP7198752B2 (en) 2016-08-09 2017-08-09 Anti-ICOS antibody
TW106126908A TWI760352B (en) 2016-08-09 2017-08-09 Anti-icos antibodies
CN201780045638.9A CN109689688B (en) 2016-08-09 2017-08-09 anti-ICOS antibody
KR1020197006706A KR102604433B1 (en) 2016-08-09 2017-08-09 anti-ICOS antibodies
BR112019002529-4A BR112019002529A2 (en) 2016-08-09 2017-08-09 isolated antibody, composition, method for modulating t-cell balance, method for treating a therapy-treatable disease or condition, method for treating cancer, igg1 antibody combination, anti-ics antibody, transgenic non-human mammal, and method for producing a antibody
CN202310348318.8A CN117736325A (en) 2016-08-09 2017-08-09 Isolated antibodies and uses thereof
RU2019104980A RU2764548C2 (en) 2016-08-09 2017-08-09 Anti-icos antibodies
US15/698,600 US9957323B2 (en) 2016-06-20 2017-09-07 Anti-ICOS antibodies
EP17840565.0A EP3559041A1 (en) 2016-12-20 2017-12-19 Multispecific antibody with combination therapy for immuno-oncology
JP2019533195A JP7290568B2 (en) 2016-12-20 2017-12-19 Multispecific antibodies in combination therapy for cancer immunotherapy
US16/471,161 US20200190191A1 (en) 2016-12-20 2017-12-19 Multispecific antibody with combination therapy for immuno-oncology
PCT/GB2017/053826 WO2018115859A1 (en) 2016-12-20 2017-12-19 Multispecific antibody with combination therapy for immuno-oncology
US17/727,309 US20220403029A1 (en) 2016-08-09 2022-04-22 Anti-icos antibodies
US17/727,288 US20220380467A1 (en) 2016-08-09 2022-04-22 Anti-icos antibodies
JP2022089801A JP7448586B2 (en) 2016-08-09 2022-06-01 Anti-ICOS antibody
JP2023016174A JP7750887B2 (en) 2016-12-20 2023-02-06 Multispecific antibodies in combination therapy for cancer immunotherapy
US18/499,431 US20240158502A1 (en) 2016-08-09 2023-11-01 Anti-icos antibodies
JP2023205810A JP7781129B2 (en) 2016-08-09 2023-12-06 Anti-ICOS antibody

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1709818.7A GB201709818D0 (en) 2017-06-20 2017-06-20 Antibodies

Publications (1)

Publication Number Publication Date
GB201709818D0 true GB201709818D0 (en) 2017-08-02

Family

ID=59462313

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1709818.7A Ceased GB201709818D0 (en) 2016-06-20 2017-06-20 Antibodies

Country Status (1)

Country Link
GB (1) GB201709818D0 (en)

Similar Documents

Publication Publication Date Title
IL268517A (en) Anti-tigit antibodies
ZA201905966B (en) Anti-lag3 antibodies
IL267797B1 (en) Anti-gpc3 antibody
SG11202000660QA (en) Anti-tigit antibodies
PT3625259T (en) Anti-sirpalpha antibodies
ZA202002141B (en) Anti-transthyretin antibodies
GB201709808D0 (en) Antibodies
IL273393A (en) Novel anti-cd3epsilon antibodies
GB201601073D0 (en) Antibodies
SG10201914130VA (en) GARP-TGF-β ANTIBODIES
GB201610044D0 (en) Antibodies
ZA201808317B (en) Anti-tnfrsf25 antibodies
GB201616699D0 (en) Antibodies
ZA202103456B (en) Anti-alpha-synuclein antibodies
GB201603291D0 (en) Antibodies
GB201720970D0 (en) Antibodies
IL271067A (en) Anti-trkb antibodies
IL273529A (en) Anti-pacap antibody
PT3484921T (en) Anti-il-22r antibodies
GB201711785D0 (en) Antibodies
GB201717006D0 (en) Anti-OPG antibodies
GB201709818D0 (en) Antibodies
GB201703071D0 (en) Antibodies
GB201701416D0 (en) Anti-OPG antibodies
GB201709592D0 (en) Antibody

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)